Alira Health Expands Its Global Clinical and Data Capabilities Through the Acquisition of CROS NT

CROS NT’s expertise in biometrics and clinical operations in Europe enhances Alira Health’s lifecycle of healthcare advisory services.

News
Category:
Published on:
June 8, 2021

FRAMINGHAM, Mass.–(BUSINESS WIRE)– Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory services firm, announced that it has acquired CROS NT (www.crosnt.com), a data-driven Contract Research Organization (CRO) headquartered in Italy with offices across Europe and the United States. CROS NT provides high quality, cost-effective biometrics and innovative solutions to help clients develop and deliver therapeutics and diagnostics that improve patient lives around the world. This acquisition brings additional expertise to Alira Health’s full spectrum of advisory and implementation services that help providers, payers and suppliers uncover opportunity, accelerate innovation, and improve outcomes for patients.

“We are extremely pleased to acquire CROS NT’s Biometrics services globally. The synergies among our Regulatory, Clinical and Real-World Evidence (RWE) practices and CROS NT’s global biometrics capabilities will enhance Alira Health’s unique ability to serve clients across their solutions lifecycle,” said Gabriele Brambilla, Chief Executive Officer at Alira Health. “The addition of CROS NT will also enable Alira Health to expand our direct clinical operations in Europe. We embrace CROS NT’s commitment and passion to being a visionary in clinical research and are proud to welcome CROS NT CEO, Paolo Morelli, and his team to our fast-growing company.”

“CROS NT is delighted to join Alira Health to better serve our clients by providing a complete portfolio of services and solutions. We are excited to contribute to Alira Health’s mission of healthcare transformation, creating value for patients,” said Paolo Morelli, CEO of CROS NT. “Our experienced team of professionals will deliver value through our combined services, accelerating innovation and delivering tomorrow’s standard of care to patients.”

Paolo Morelli will join Alira Health’s leadership as Executive Vice President, Biometrics, and will lead the growth of Alira Health’s Data Science services.

About CROS NT:

CROS NT is a global biometrics service provider with 28+ years of experience in business, focused on clinical and observational trials. In addition, we support our clients with a full-service clinical offering delivered through a network of trusted partners.

CROS NT has offices in Bologna and Verona, Italy; London, England; Chapel Hill, NC, U.S.

 

Read the press release on BusinessWire here.

To learn more about Alira Health

Contact us

Related news

Clinical
Publications April 6, 2021
Unlocking the Database Lock Process
In our latest whitepaper, in collaboration with CROS NT, Alira Health’s Vice President Clinical Development, Christopher Rao and Amanda Cross, US Country Manager Executive Director,(...)
Clinical Regulatory
News January 7, 2021
Alira Health Adds CMC Services through Acquisition of Chamow & Associates
We have acquired Chamow & Associates (www.chamowassociates.com), a California-based integrated CMC advisory firm. This acquisition brings expertise in biologics manufacturing, quality(...)
Clinical
Publications September 4, 2020
Clinical Trial Management – The Dharmic Approach
In this article, Sheryl Kelley, Alira Health’s Associate Director of Data Quality and Finance (and certified yoga instructor), writes about the connections between yoga, dharma, and(...)
Clinical
Publications July 1, 2020
Clinical Trials Trends: Remote Monitoring
The COVID-19 pandemic caused an urgent need to transition clinical trials from on-site to remote monitoring. Though the concept of remote monitoring existed before the pandemic, with(...)
Clinical
Publications May 6, 2020
What You Should Know before Selecting a CRO
When running a clinical trial, it is important to choose the right CRO. This choice impacts the quality and experience of conducting the study.
Clinical
Publications May 1, 2020
Four Critical Factors for Clinical Trial Budget Success
Planning a relevant and accurate budget, regardless of the trial phase or indication, can be one of the most challenging aspects of the clinical trial process. Though it is one of(...)
Clinical
Publications May 1, 2020
Clinical Trial Guidance for Sponsors: Four Critical Steps for Clinical Trial Success
As many seasoned clinical trial sponsors know, there are several factors that affect the outcome of a trial. While some of these factors are out of their control, there are a few fundamental(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.